|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K2319/30 | (2013.01) |
| A61K 38/18 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2319/32 | (2013.01) | ||
| A61P 17/02 | (2006.01) | ||
| C07K 14/475 | (2013.01) | ||
| C07K 19/00 | (2006.01) | ||
| C07K2319/31 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 38/1816 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/16 | (2013.01) | ||
| A61K 31/17 | (2013.01) | ||
| A61K 31/4196 | (2013.01) | ||
| A61K 31/4422 | (2013.01) | ||
| A61K 38/1793 | (2013.01) | ||
| A61P 17/02 | (2018.01) | ||
| A61P 7/06 | (2018.01) | ||
| A61K 38/179 | (2013.01) | ||
| C12Y 207/1103 | (2013.01) |
| (11) | Patento numeris | 3154566 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15806256.2 |
| Europos patento paraiškos padavimo data | 2015-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/035706 |
| Data | 2015-06-12 |
| (87) | Numeris | WO 2015/192111 |
| Data | 2015-12-17 |
| (30) | Numeris | Data | Šalis |
| 201462012109 P | 2014-06-13 | US | |
| 201462045808 P | 2014-09-04 | US |
| (72) |
ATTIE, Kenneth, M. , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTRII ANTAGONIST FOR THE TREATMENT OR PREVENTION OF A CUTANEOUS ULCER IN A SUBJECT THAT HAS ANEMIA |
| ACTRII ANTAGONIST FOR THE TREATMENT OR PREVENTION OF A CUTANEOUS ULCER IN A SUBJECT THAT HAS ANEMIA |